NASDAQ:HQY - HealthEquity Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $74.33
  • Forecasted Upside: 22.02 %
  • Number of Analysts: 11
  • Breakdown:
  • 1 Sell Ratings
  • 0 Hold Ratings
  • 10 Buy Ratings
  • 0 Strong Buy Ratings
$60.92
▲ +0.38 (0.63%)

This chart shows the closing price for HQY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New HealthEquity Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HQY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HQY

Analyst Price Target is $74.33
▲ +22.02% Upside Potential
This price target is based on 11 analysts offering 12 month price targets for HealthEquity in the last 3 months. The average price target is $74.33, with a high forecast of $95.00 and a low forecast of $56.00. The average price target represents a 22.02% upside from the last price of $60.92.

This chart shows the closing price for HQY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 11 contributing investment analysts is to buy stock in HealthEquity. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 12 buy ratings
  • 1 hold ratings
  • 0 sell ratings
2/16/2021
  • 0 strong buy ratings
  • 10 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/17/2021
  • 0 strong buy ratings
  • 11 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/15/2021
  • 0 strong buy ratings
  • 10 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/13/2021
  • 0 strong buy ratings
  • 10 buy ratings
  • 1 hold ratings
  • 0 sell ratings
2/11/2022
  • 0 strong buy ratings
  • 12 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/12/2022
  • 0 strong buy ratings
  • 10 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/11/2022
  • 0 strong buy ratings
  • 10 buy ratings
  • 0 hold ratings
  • 1 sell ratings
8/10/2022

Latest Recommendations

  • 0 strong buy ratings
  • 10 buy ratings
  • 0 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/12/2022The Goldman Sachs GroupInitiated CoverageSell$59.00N/A
6/8/2022Deutsche Bank AktiengesellschaftBoost Price Target$66.00 ➝ $67.00Low
6/7/2022Barrington ResearchBoost Price Target$70.00 ➝ $75.00Low
6/7/2022SVB LeerinkBoost Price TargetOutperform$67.00 ➝ $76.00Low
4/11/2022Wells Fargo & CompanyInitiated CoverageOverweight$95.00Medium
4/6/2022GuggenheimInitiated CoverageBuy$89.00Low
3/30/2022BTIG ResearchUpgradeNeutral ➝ Buy$85.00Medium
3/28/2022Jefferies Financial GroupBoost Price TargetBuy$62.00 ➝ $80.00Medium
3/24/2022Deutsche Bank AktiengesellschaftBoost Price TargetBuy$62.00 ➝ $66.00High
3/23/2022Bank of AmericaBoost Price Target$63.00 ➝ $70.00High
3/23/2022Barrington ResearchBoost Price Target$55.00 ➝ $70.00High
2/24/2022Deutsche Bank AktiengesellschaftBoost Price TargetBuy$52.00 ➝ $62.00Low
12/21/2021JPMorgan Chase & Co.Lower Price TargetOverweight$82.00 ➝ $56.00High
12/8/2021Deutsche Bank AktiengesellschaftLower Price TargetBuy ➝ Buy$75.00 ➝ $52.00Medium
12/7/2021Barrington ResearchLower Price TargetOutperform ➝ Outperform$80.00 ➝ $55.00High
12/7/2021Royal Bank of CanadaLower Price TargetOutperform ➝ Outperform$87.00 ➝ $70.00High
12/7/2021Raymond JamesDowngradeStrong-Buy ➝ Outperform$90.00 ➝ $70.00High
12/1/2021Jefferies Financial GroupInitiated CoverageBuy$68.00High
9/21/2021Deutsche Bank AktiengesellschaftLower Price TargetIn-Line ➝ Buy$92.00 ➝ $75.00Low
9/9/2021Barrington ResearchReiterated RatingBuy$90.00Medium
9/9/2021SVB LeerinkUpgradeMarket Perform ➝ Outperform$80.00High
7/1/2021StephensInitiated CoverageOverweight$100.00Low
6/10/2021Raymond JamesBoost Price TargetStrong-Buy$85.00 ➝ $90.00Low
6/8/2021BTIG ResearchReiterated RatingHoldHigh
6/8/2021Cantor FitzgeraldBoost Price TargetOverweight$82.00 ➝ $85.00High
5/24/2021Robert W. BairdReiterated RatingNeutral ➝ Hold$86.00Low
4/29/2021JPMorgan Chase & Co.Initiated CoverageOverweightLow
3/22/2021Raymond JamesLower Price TargetStrong-Buy$100.00 ➝ $85.00Low
3/17/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$88.00 ➝ $92.00Medium
3/16/2021SVB LeerinkBoost Price TargetMarket Perform$77.00 ➝ $80.00High
2/10/2021Raymond JamesBoost Price TargetStrong-Buy$75.00 ➝ $100.00Low
2/9/2021Barrington ResearchReiterated RatingOutperform$75.00 ➝ $90.00Low
2/9/2021Truist FinancialBoost Price Target$80.00 ➝ $92.00Low
2/9/2021Royal Bank of CanadaBoost Price TargetOutperform$74.00 ➝ $87.00Low
1/6/2021BTIG ResearchInitiated CoverageNeutralN/A
1/6/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$60.00 ➝ $77.00N/A
12/8/2020Cantor FitzgeraldBoost Price TargetOverweight$70.00 ➝ $77.00High
12/8/2020JPMorgan Chase & Co.Boost Price TargetOverweight$61.00 ➝ $72.00High
12/8/2020Barrington ResearchBoost Price TargetOutperform$70.00 ➝ $75.00Low
12/8/2020Royal Bank of CanadaBoost Price TargetOutperform$67.00 ➝ $74.00Medium
12/2/2020SVB LeerinkBoost Price TargetMarket Perform$64.00 ➝ $77.00High
11/23/2020GuggenheimDowngradeBuy ➝ NeutralMedium
10/23/2020Royal Bank of CanadaInitiated CoverageOutperform$67.00High
9/10/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$57.00 ➝ $60.00High
9/9/2020Barrington ResearchBoost Price TargetOutperform$65.00 ➝ $70.00Low
9/9/2020Wells Fargo & CompanyBoost Price TargetOverweight$63.00 ➝ $70.00High
9/9/2020SVB LeerinkBoost Price TargetPositive ➝ Market Perform$51.00 ➝ $64.00High
9/9/2020Raymond JamesReiterated RatingBuyHigh
6/3/2020Cantor FitzgeraldLower Price TargetOverweight$80.00 ➝ $70.00Low
6/1/2020Barrington ResearchReiterated RatingBuy$65.00Low
4/20/2020Cantor FitzgeraldReiterated RatingBuy$80.00High
4/14/2020GuggenheimInitiated CoverageBuy$56.00Medium
4/13/2020SVB LeerinkInitiated CoverageMarket Perform$53.00Medium
4/8/2020Raymond JamesLower Price TargetStrong-Buy$90.00 ➝ $75.00High
3/27/2020Raymond JamesLower Price TargetReduce ➝ Strong-Buy$110.00 ➝ $90.00High
3/26/2020SunTrust BanksBoost Price TargetBuy$55.00 ➝ $68.00Medium
3/18/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$88.00 ➝ $57.00Low
3/17/2020Barrington ResearchLower Price TargetOutperform$86.00 ➝ $65.00High
3/17/2020SunTrust BanksLower Price TargetBuy$87.00 ➝ $55.00High
3/17/2020Robert W. BairdLower Price TargetNeutral$74.00 ➝ $47.00High
3/17/2020KeyCorpLower Price TargetOverweight$86.00 ➝ $65.00High
3/17/2020Cantor FitzgeraldReiterated RatingOverweight$90.00 ➝ $80.00High
2/20/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$74.00 ➝ $88.00Low
2/19/2020Barrington ResearchReiterated RatingBuy$86.00High
2/19/2020Wells Fargo & CompanyBoost Price TargetOverweight$80.00 ➝ $87.00High
2/19/2020KeyCorpBoost Price TargetOverweight$80.00 ➝ $86.00High
1/8/2020Wells Fargo & CompanyBoost Price TargetOverweight$76.00 ➝ $80.00Medium
12/4/2019Cantor FitzgeraldReiterated RatingBuy$95.00High
12/4/2019KeyCorpReiterated RatingBuy$70.00 ➝ $77.00High
12/2/2019Barrington ResearchReiterated RatingBuy$75.00High
10/7/2019The Goldman Sachs GroupInitiated CoverageNeutral$56.00 ➝ $56.00Medium
9/30/2019KeyCorpSet Price TargetBuy$70.00High
9/17/2019KeyCorpLower Price TargetOverweight$90.00 ➝ $70.00Low
9/12/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuy$74.00Low
9/9/2019SunTrust BanksLower Price TargetBuy$80.00Medium
9/9/2019Raymond JamesUpgradeOutperform ➝ Strong-Buy$90.00 ➝ $80.00Medium
9/4/2019Bank of AmericaSet Price TargetBuy$79.00Low
9/4/2019Barrington ResearchReiterated RatingOutperform$100.00 ➝ $75.00High
9/4/2019OppenheimerLower Price TargetOutperform$98.00 ➝ $76.00High
9/4/2019Wells Fargo & CompanyLower Price TargetOutperformer$80.00 ➝ $76.00High
7/19/2019Raymond JamesBoost Price TargetOutperform$85.00 ➝ $90.00Medium
7/19/2019Bank of AmericaUpgradeNeutral ➝ Buy$75.00 ➝ $90.00High
6/28/2019CitigroupReiterated RatingBuyMedium
6/10/2019Raymond JamesBoost Price TargetOutperform$80.00 ➝ $85.00Low
6/5/2019Bank of AmericaReiterated RatingNeutral ➝ Neutral$83.00 ➝ $75.00High
6/5/2019JPMorgan Chase & Co.Set Price TargetOverweight$91.00 ➝ $80.00High
5/10/2019CitigroupReiterated RatingBuyMedium
3/19/2019OppenheimerBoost Price TargetOutperform$74.00 ➝ $98.00Medium
3/19/2019Bank of AmericaBoost Price TargetNeutral ➝ Neutral$82.00 ➝ $83.00High
3/19/2019KeyCorpBoost Price TargetOverweight ➝ Overweight$74.00 ➝ $90.00High
3/19/2019Cantor FitzgeraldBoost Price TargetOverweight$83.00 ➝ $90.00High
3/1/2019Bank of AmericaReiterated RatingNeutral ➝ Neutral$67.00 ➝ $82.00Medium
2/7/2019Cantor FitzgeraldBoost Price TargetOverweight$80.00 ➝ $83.00High
2/7/2019Chardan CapitalReiterated RatingBuy ➝ Buy$82.00 ➝ $78.00High
2/7/2019SunTrust BanksUpgradeHold ➝ Buy$81.00High
1/8/2019CitigroupSet Price TargetBuy$102.00Medium
12/17/2018Cantor FitzgeraldUpgradeNeutral ➝ Overweight$82.00High
12/7/2018Wells Fargo & CompanyLower Price TargetOutperform ➝ Outperform$100.00 ➝ $90.00High
12/6/2018Cantor FitzgeraldBoost Price TargetNeutral ➝ Neutral$80.00 ➝ $82.00High
12/6/2018SunTrust BanksDowngradeBuy ➝ Hold$105.00 ➝ $90.00High
9/10/2018Raymond JamesBoost Price TargetOutperform ➝ Outperform$85.00 ➝ $105.00Low
9/6/2018Bank of AmericaDowngradeBuy ➝ Neutral$84.00 ➝ $105.00Low
9/5/2018Barrington ResearchReiterated RatingOutperform$100.00Medium
9/5/2018SunTrust BanksBoost Price TargetBuy$105.00Medium
9/5/2018OppenheimerBoost Price TargetOutperform$85.00 ➝ $104.00High
9/5/2018Cantor FitzgeraldBoost Price TargetNeutral ➝ Neutral$68.00 ➝ $80.00High
9/5/2018Wells Fargo & CompanyBoost Price TargetOutperform ➝ Outperform$84.00 ➝ $105.00High
9/5/2018CitigroupReiterated RatingBuy$110.00High
9/4/2018KeyCorpBoost Price TargetOverweight ➝ Overweight$90.00 ➝ $105.00Low
7/19/2018KeyCorpBoost Price TargetBuy$82.00 ➝ $90.00Low
6/5/2018Barrington ResearchBoost Price TargetOutperform$85.00High
6/5/2018OppenheimerBoost Price TargetOutperform$68.00 ➝ $85.00Low
6/5/2018Robert W. BairdBoost Price TargetNeutral ➝ Neutral$61.00 ➝ $77.00Low
6/5/2018SunTrust BanksBoost Price TargetBuy$70.00 ➝ $85.00Low
6/5/2018KeyCorpBoost Price TargetOverweight ➝ Overweight$72.00 ➝ $82.00Low
6/4/2018Cantor FitzgeraldReiterated RatingNeutral ➝ Hold$65.00 ➝ $68.00Low
5/30/2018Cantor FitzgeraldDowngradeOverweight ➝ Neutral$65.00High
5/23/2018Bank of AmericaInitiated CoverageBuy$83.00Medium
4/24/2018JPMorgan Chase & Co.Initiated CoverageOverweight ➝ Overweight$60.00 ➝ $69.00Low
4/5/2018KeyCorpBoost Price TargetOverweight ➝ Overweight$66.00 ➝ $72.00Low
3/23/2018Cantor FitzgeraldReiterated RatingBuy$65.00Low
3/20/2018Barrington ResearchBoost Price TargetOutperform$65.00High
3/20/2018OppenheimerBoost Price TargetOutperform ➝ Outperform$58.00 ➝ $68.00High
3/20/2018KeyCorpBoost Price TargetOverweight ➝ Overweight$62.00 ➝ $66.00High
3/20/2018Chardan CapitalBoost Price TargetBuy ➝ Buy$62.00 ➝ $77.00High
3/20/2018Robert W. BairdBoost Price TargetNeutral ➝ Neutral$49.00 ➝ $61.00High
3/20/2018CitigroupBoost Price TargetOutperform$58.00 ➝ $68.00High
3/20/2018SunTrust BanksBoost Price TargetPositive ➝ Buy$70.00High
2/22/2018Cantor FitzgeraldReiterated RatingBuy$60.00High
2/7/2018Cantor FitzgeraldBoost Price TargetOverweight ➝ Overweight$56.00 ➝ $60.00Medium
2/7/2018Robert W. BairdBoost Price TargetNeutral ➝ Neutral$48.00 ➝ $49.00Medium
1/24/2018JPMorgan Chase & Co.Lower Price TargetOverweight ➝ Overweight$52.00 ➝ $51.00Low
1/4/2018CitigroupInitiated CoverageBuyMedium
12/6/2017Chardan CapitalBoost Price TargetBuy ➝ Buy$58.00 ➝ $62.00High
12/5/2017Cantor FitzgeraldReiterated RatingBuy$56.00Low
9/25/2017Cantor FitzgeraldReiterated RatingBuy$56.00Low
9/21/2017Robert W. BairdReiterated RatingNeutral ➝ HoldMedium
9/6/2017OppenheimerReiterated RatingBuy$61.00Low
9/5/2017Cantor FitzgeraldReiterated RatingBuy$56.00Low
8/29/2017Cantor FitzgeraldReiterated RatingBuy$56.00Medium
(Data available from 8/11/2017 forward)

News Sentiment Rating

0.58 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 4 very positive mentions
  • 12 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
1/13/2022
  • 5 very positive mentions
  • 10 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
2/12/2022
  • 6 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/14/2022
  • 6 very positive mentions
  • 21 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
4/13/2022
  • 5 very positive mentions
  • 8 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
5/13/2022
  • 7 very positive mentions
  • 20 positive mentions
  • 5 negative mentions
  • 0 very negative mentions
6/12/2022
  • 6 very positive mentions
  • 12 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
7/12/2022
  • 7 very positive mentions
  • 17 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
8/11/2022

Current Sentiment

  • 7 very positive mentions
  • 17 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
HealthEquity logo
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. The company was incorporated in 2002 and is headquartered in Draper, Utah.
Read More

Today's Range

Now: $60.92
Low: $60.57
High: $61.24

50 Day Range

MA: $61.95
Low: $56.95
High: $69.01

52 Week Range

Now: $60.92
Low: $36.81
High: $73.29

Volume

4,246 shs

Average Volume

622,123 shs

Market Capitalization

$5.14 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.96

Frequently Asked Questions

What sell-side analysts currently cover shares of HealthEquity?

The following equities research analysts have issued reports on HealthEquity in the last twelve months: Bank of America Co., Barrington Research, BTIG Research, Deutsche Bank Aktiengesellschaft, Guggenheim, Jefferies Financial Group Inc., JPMorgan Chase & Co., Raymond James, Royal Bank of Canada, StockNews.com, SVB Leerink LLC, The Goldman Sachs Group, Inc., TheStreet, and Wells Fargo & Company.
View the latest analyst ratings for HQY.

What is the current price target for HealthEquity?

12 Wall Street analysts have set twelve-month price targets for HealthEquity in the last year. Their average twelve-month price target is $74.33, suggesting a possible upside of 22.8%. Wells Fargo & Company has the highest price target set, predicting HQY will reach $95.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $56.00 for HealthEquity in the next year.
View the latest price targets for HQY.

What is the current consensus analyst rating for HealthEquity?

HealthEquity currently has 1 sell rating and 10 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe HQY will outperform the market and that investors should add to their positions of HealthEquity.
View the latest ratings for HQY.

What other companies compete with HealthEquity?

Other companies that are similar to HealthEquity include MultiPlan, Nutex Health, American Well, Phreesia and LHC Group. Learn More about companies similar to HealthEquity.

How do I contact HealthEquity's investor relations team?

HealthEquity's physical mailing address is 15 WEST SCENIC POINTE DRIVE SUITE 100, DRAPER UT, 84020. The company's listed phone number is (801) 727-1000 and its investor relations email address is [email protected] The official website for HealthEquity is www.healthequity.com. Learn More about contacing HealthEquity investor relations.